Discussion Group Report
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry at Biogen, leads a discussion group on what the revolutionary machine learning technology means for drug design.
By Tom Cohen |
21 April 2022
Computational Drug Design & AI